| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |